Search - tctmd.com

Displaying 521 - 540 of 963

Sort: Relevancy | Date

Presentation TCT 2019

What is a High Risk PFO, and Should it Affect the Decision to Close?

Presenter: Jonathan Tobis

September 27, 2019

Presentation TCT 2019

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

Presenter: Clifford Kavinsky

September 27, 2019

Presentation TCT 2019

PFO in 2019, A Neurologist’s Perspective

Presenter: David Thaler

September 27, 2019

Presentation TCT 2019

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

Presenter: Andrew Goldsweig, MD

September 27, 2019

Presentation TCT 2019

PFO Closure for Primary Prevention: The Debate Has Started — A Case Example and a Clinical Trial Proposal

Presenter: Fabian Nietlispach

September 27, 2019

Presentation TCT 2019

PFO Closure for Stroke: The Debate Is Over

Presenter: Stephen Brecker

September 27, 2019

Presentation TCT 2019

Strokes After TAVR Are Rare and Cerebral Protection Is Unnecessary

Presenter: David Hildick-Smith

September 26, 2019

Presentation TCT 2019

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Presenter: Fabian Nietlispach

September 26, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Michael O'Riordan

August 19, 2019

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Todd Neale

August 16, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

Advertisement

What is a High Risk PFO, and Should it Affect the Decision to Close?

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

PFO in 2019, A Neurologist’s Perspective

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

PFO Closure for Primary Prevention: The Debate Has Started — A Case Example and a Clinical Trial Proposal

PFO Closure for Stroke: The Debate Is Over

Strokes After TAVR Are Rare and Cerebral Protection Is Unnecessary

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Aborted TAVR Procedures Are Waning in the US

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content